Level of evidence for therapeutic drug monitoring of vancomycin

Vancomycin is an antibiotic for exclusive hospital use administrated in intravenous infusion to treat systemic infections. It is mainly eliminated by kidneys and potentially nephrotoxic. Data available show that Therapeutic Drug Monitoring (TDM) of vancomycin is highly recommended. It aims to ensure...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Therapie 2011-01, Vol.66 (1), p.29
Hauptverfasser:	Jelassi, Mohamed Larbi, Benlmouden, Amine, Lefeuvre, Sandrine, Mainardi, Jean-Luc, Billaud, Eliane M
Format:	Artikel
Sprache:	fre
Schlagworte:	Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - adverse effects Anti-Bacterial Agents - economics Anti-Bacterial Agents - pharmacokinetics Anti-Bacterial Agents - therapeutic use Bacterial Infections - drug therapy Bacterial Infections - economics Bacterial Infections - microbiology Dose-Response Relationship, Drug Drug Monitoring - methods Evidence-Based Medicine Humans Infusions, Intravenous Kidney Diseases - complications Kidney Diseases - metabolism Vancomycin - administration & dosage Vancomycin - adverse effects Vancomycin - economics Vancomycin - pharmacokinetics Vancomycin - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!